Soffer Gary, Cohen Barrie, Toh Jennifer, Edelman Devorah, Garg Karan, Jariwala Sunit
1 Division of Allergy and Immunology, Montefiore Medical Center, Bronx, NY, USA.
2 Department of Pediatrics, Children's Hospital at Montefiore, Bronx, NY, USA.
Vasc Endovascular Surg. 2018 Jan;52(1):59-60. doi: 10.1177/1538574417736420. Epub 2017 Oct 30.
We present a case of an 82-year-old male with known radiocontrast media (RCM) hypersensitivity who was admitted to our hospital with gangrene of his right toe. The plan for revascularization of his lower extremity required an angiogram. This presented a management challenge as the patient had experienced 2 episodes of delayed anaphylaxis to Omnipaque (iohexol) RCM, and based on a literature review, there was no known or established precedent on a safe procedure in these situations. The patient was premedicated and given a graded dose challenge of an alternative RCM (iodixanol) prior to the radiographic study. He was given 1% of the total expected dose 1 hour before to the procedure and an additional 10% for the 30 minutes prior. He was then given the final dose in the operating room. Following angiogram, the patient was monitored for 18 hours in the postanesthesia care unit, with no adverse reactions. He was placed on a prednisone taper for 1 week, with daily diphenhydramine. The patient remained asymptomatic throughout the hospital course. This novel approach to RCM hypersensitivity management lends itself to a hope that graded dose challenges may play a greater role in the management of these patients.
我们报告一例82岁男性患者,已知对放射性造影剂(RCM)过敏,因右脚趾坏疽入院。其下肢血管重建计划需要进行血管造影。这带来了管理上的挑战,因为该患者曾有2次对欧乃派克(碘海醇)RCM延迟过敏反应,且经文献检索,在这些情况下尚无已知的安全操作先例。在进行影像学检查前,该患者接受了预处理,并给予了替代RCM(碘克沙醇)的分级剂量激发试验。在操作前1小时给予预期总剂量的1%,在操作前30分钟再给予额外的10%。然后在手术室给予最终剂量。血管造影后,患者在麻醉后护理单元监测18小时,未出现不良反应。患者接受了为期1周的泼尼松逐渐减量治疗,并每日服用苯海拉明。患者在整个住院过程中均无症状。这种处理RCM过敏的新方法带来了一种希望,即分级剂量激发试验可能在这些患者的管理中发挥更大作用。